Regeneron Pharmaceuticals (REGN)
Equity Ratio
75.99%
Quarterly · Period ending:
REGN Equity Ratio
Latest reported75.99%period ending
Latest reported75.99%period ending
REGN Quarterly Equity Ratio (48.03% → 75.99%)
Latest values, visible window
High-resolution chart · PNG
REGN equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 75.9909% | |
| 76.889% | |
| 77.0658% | |
| 77.0681% | |
| 78.3347% | |
| 78.2726% | |
| 77.7385% | |
| 78.3237% | |
| 78.161% | |
| 78.5319% | |
| 78.5155% | |
| 77.4311% | |
| 78.3427% | |
| 78.1613% | |
| 77.5779% | |
| 77.4585% | |
| 76.0419% | |
| 75.5813% | |
| 73.7918% | |
| 72.9062% | |
| 70.4057% | |
| 67.3918% | |
| 64.2376% | |
| 62.9539% | |
| 62.7735% | |
| 76.9983% | |
| 74.9041% | |
| 75.3582% | |
| 74.0564% | |
| 73.4722% | |
| 74.6287% | |
| 72.8168% | |
| 72.211% | |
| 70.0721% | |
| 70.1036% | |
| 69.5488% | |
| 68.1037% | |
| 62.2463% | |
| 63.8025% | |
| 65.7767% | |
| 65.6981% | |
| 63.7667% | |
| 65.1587% | |
| 63.6103% | |
| 73.746% | |
| 70.7724% | |
| 65.6622% | |
| 68.2402% | |
| 68.5413% | |
| 67.8215% | |
| 66.1494% | |
| 64.0116% | |
| 62.7912% | |
| 61.7904% | |
| 59.8602% | |
| 48.5377% | |
| 40.7998% | |
| 37.3307% | |
| 36.6983% | |
| 43.5645% | |
| 45.6634% | |
| 48.2262% | |
| 48.4486% | |
| 36.9325% | |
| 46.9513% | |
| 49.0717% | |
| 53.5295% | |
| 56.9183% | |
| 55.2985% | |
| 60.2153% | |
| 62.5117% | |
| 52.9044% | |
| 52.9821% | |
| 49.4806% | |
| 49.1603% | |
| 26.4174% | |
| 29.9964% | |
| 32.7035% | |
| 37.024% | |
| 17.5888% | |
| 22.1411% | |
| 25.4478% | |
| 26.9189% | |
| 32.5278% | |
| 36.9305% | |
| 39.504% | |
| 38.5838% | |
| 37.8419% | |
| 38.9472% | |
| 40.323% | |
| 28.7022% | |
| 31.2091% | |
| 34.8487% | |
| 38.4757% | |
| 37.2806% | |
| 43.1895% | |
| 48.3956% | |
| 51.3884% | |
| 53.766% | |
| 92.5483% |